These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19414666)

  • 1. To make progress in rare cancers, patients must lead the way.
    Dockser Marcus A
    J Clin Oncol; 2009 Jun; 27(16):2575-7. PubMed ID: 19414666
    [No Abstract]   [Full Text] [Related]  

  • 2. Collaboration is key to treating uncommon cancers: scientists and patients champion research in these rare diseases.
    Printz C
    Cancer; 2010 Jun; 116(12):2847-9. PubMed ID: 20564387
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical research. Advocating, the clinical way.
    Couzin J
    Science; 2005 May; 308(5724):940-2. PubMed ID: 15890856
    [No Abstract]   [Full Text] [Related]  

  • 4. [Place of the expert patient in the R&D process in the field of rare diseases].
    Aïach K
    Med Sci (Paris); 2018 May; 34 Hors série n°1():28-29. PubMed ID: 29911552
    [No Abstract]   [Full Text] [Related]  

  • 5. Patients with rare diseases work to jump-start research; advocacy groups create their own tissue banks to aid in drug treatment.
    Marcus AD
    Wall St J (East Ed); 2006 Jul; ():D1, D2. PubMed ID: 16906687
    [No Abstract]   [Full Text] [Related]  

  • 6. Patients often go without effective new treatments, especially in rare disease patient populations where profit potential is limited.
    Bloom BE
    Contemp Clin Trials; 2011 Mar; 32(2):151-2. PubMed ID: 21238613
    [No Abstract]   [Full Text] [Related]  

  • 7. International Rare Disease Research Consortium commits to aggressive goals.
    Baxter K; Terry SF
    Genet Test Mol Biomarkers; 2011; 15(7-8):465. PubMed ID: 21762001
    [No Abstract]   [Full Text] [Related]  

  • 8. Disease research: Rare insights.
    Ledford H
    Nature; 2014 Jan; 505(7483):443-5. PubMed ID: 24436966
    [No Abstract]   [Full Text] [Related]  

  • 9. Cuts to research funding could hurt health care too.
    Ahmed K; Ashrafian H
    Nature; 2009 Mar; 458(7234):29. PubMed ID: 19262650
    [No Abstract]   [Full Text] [Related]  

  • 10. Patient advocacy in Diamond Blackfan anemia: facilitating translational research and progress towards the cure of a rare disease.
    Arturi MC
    Semin Hematol; 2011 Apr; 48(2):75-80. PubMed ID: 21435503
    [No Abstract]   [Full Text] [Related]  

  • 11. A patient rallies, and a field awakens.
    Nelson B
    Cancer Cytopathol; 2018 Jul; 126(7):443-444. PubMed ID: 30699247
    [No Abstract]   [Full Text] [Related]  

  • 12. [Optimising treatment for people with rare diseases].
    Lund AM; Skovby F
    Ugeskr Laeger; 2006 Apr; 168(15):1547-50. PubMed ID: 16640978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bottling a healthy idea. A former Microsoft exec's start-up finances cancer research.
    Hannon K
    US News World Rep; 2007 Oct; 143(12):54. PubMed ID: 17958194
    [No Abstract]   [Full Text] [Related]  

  • 14. development of a therapeutic approach to rare cancers in children: the Children's Oncology Group experience.
    Pashankar FD; Rodriguez-Galindo C; Pappo A
    J Pediatr Hematol Oncol; 2012 May; 34 Suppl 2():S37-8. PubMed ID: 22525404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The founding of the European Cooperative Study Group on Pediatric Rare Tumors--EXPeRT.
    Ferrari A; Schneider DT; Bisogno G;
    Expert Rev Anticancer Ther; 2013 Jan; 13(1):1-3. PubMed ID: 23259419
    [No Abstract]   [Full Text] [Related]  

  • 16. The value of research collaborations and consortia in rare cancers.
    Blay JY; Coindre JM; Ducimetière F; Ray-Coquard I
    Lancet Oncol; 2016 Feb; 17(2):e62-e69. PubMed ID: 26868355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
    Petrelli NJ; Winer EP; Brahmer J; Dubey S; Smith S; Thomas C; Vahdat LT; Obel J; Vogelzang N; Markman M; Sweetenham JW; Pfister D; Kris MG; Schuchter LM; Sawaya R; Raghavan D; Ganz PA; Kramer B
    J Clin Oncol; 2009 Dec; 27(35):6052-69. PubMed ID: 19901123
    [No Abstract]   [Full Text] [Related]  

  • 18. [Crucial role of patients in biobanking: national and international examples].
    van der Valk T; Smit C
    Ned Tijdschr Geneeskd; 2011; 155():A2968. PubMed ID: 21486507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dilemmas of studying rare diseases].
    Varga O
    Lege Artis Med; 2014 Apr; 24(4):218-21. PubMed ID: 25137764
    [No Abstract]   [Full Text] [Related]  

  • 20. [Why does knowledge on rare diseases allow progress in treatments?].
    Argiroffo CB; Superti-Furga A
    Rev Med Suisse; 2012 Feb; 8(329):395-6. PubMed ID: 22432238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.